Name: Genetic Diseases or Conditions: Cystic Fibrosis, the Salty Kiss (Human Diseases and Conditions Collection) (en Inglés)
Price: 61850.00 CLP
Availability: InStock
Author: Todd Eckdahl
ISBN: 9781944749552

portada Genetic Diseases or Conditions: Cystic Fibrosis, the Salty Kiss (Human Diseases and Conditions Collection) (en Inglés)

Formato

Libro Físico

Editorial

Momentum Press

Autor

Todd Eckdahl

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

ISBN13

9781944749552

Categorías

Genética (no médica)

Genetic Diseases or Conditions: Cystic Fibrosis, the Salty Kiss (Human Diseases and Conditions Collection) (en Inglés)

Todd Eckdahl (Autor) · Momentum Press · Tapa Blanda

Libro Nuevo

$ 61.850

$ 123.700

Ahorras: $ 61.850

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 05 de Junio y el Lunes 17 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Genetic Diseases or Conditions: Cystic Fibrosis, the Salty Kiss (Human Diseases and Conditions Collection) (en Inglés)"

Cystic fibrosis (CF) is one of the most common genetic diseases, affecting about 70,000 people throughout the world, with over 1,000 new cases diagnosed each year. This book describes the symptoms of CF including lung disease, digestive problems, pancreatic insufficiency, liver disease, intestinal obstruction, and infertility. It explains how CF is caused by mutations in the CFTR gene encoding a protein ion channel that maintains the balance of salt and water in the lungs and other organs. The book presents CF as an autosomal recessive disease that can arise in families with no prior history of CF. The reader will learn about treatments and therapies for CF, including antibiotics for infections, medicines for improved digestion, respiratory therapy, and pancreatic enzyme replacement. The book describes promising new pharmaceutical discoveries that enable personalized medicine for the treatment of CF. It evaluates the prospects for curing CF through gene therapy and explains how genome editing may be used in the future to correct the CFTR gene mutations underlying CF.